Clinical Trial Update: A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing vincristine to sirolimus for high-risk vascular tumors including Kaposiform Hemangioendothelioma and Kasabach-Merritt Syndrome …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposiform Hemangioendothelioma
• Kasabach-merritt Syndrome
• Tufted Angioma

Drugs mentioned

• Sirolimus (Sirolimus)
• Vincristine (vincristine)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Kaposiform Hemangioendothelioma (KHE), Kasabach-Merritt Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2021-05-24